Be part of the knowledge.™

General Ophthalmology

2

LikeLikedUnlike

1-15 of 23

Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
- Marlana Orloff, MD
  Peer
- Gregory Daniels, MD, PhD
  Peer
- Jesse Keller, MD
  Peer
1.00 credits
MinuteCE®
Lighting the Way: Exploring the Potential of Photobiomodulation for Dry AMD Treatment
- Janis T. Eells, Ph.D.
  Peer
- David Boyer, MD
  Peer
- Diana V. Do, MD
  Peer
- Marion Munk, MD, Ph.D
  Peer
1.00 credits 8 episodes
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
MinuteCE®
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
- Janis T. Eells, Ph.D.
  Peer
1.00 program credits
Clinical and Safety Outcomes from the LIGHTSITE III Trial
MinuteCE®
Clinical and Safety Outcomes from the LIGHTSITE III Trial
- David Boyer, MD
  Peer
- Diana V. Do, MD
  Peer
1.00 program credits
Anatomical Outcomes from the LIGHTSITE III Trial
MinuteCE®
Anatomical Outcomes from the LIGHTSITE III Trial
- Diana V. Do, MD
  Peer
- David Boyer, MD
  Peer
1.00 program credits
Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
MinuteCE®
Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
- Marion Munk, MD, Ph.D
  Peer
- David Boyer, MD
  Peer
1.00 program credits
advertisement
Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection
MinuteCE®
Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection
- Marion Munk, MD, Ph.D
  Peer
- Diana V. Do, MD
  Peer
1.00 program credits
Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice
MinuteCE®
Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice
- Diana V. Do, MD
  Peer
- Marion Munk, MD, Ph.D
  Peer
1.00 program credits
Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape
MinuteCE®
Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape
- David Boyer, MD
  Peer
- Marion Munk, MD, Ph.D
  Peer
1.00 program credits
Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications
MinuteCE®
Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications
- Marion Munk, MD, Ph.D
  Peer
- David Boyer, MD
  Peer
1.00 program credits
MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
- Justis P. Ehlers, MD, FASRS
  Peer
- Roger A. Goldberg, MD, MBA
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 credits 10 episodes
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®
Second-Generation Biomarkers for Treatment Outcomes
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
advertisement
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®
Beyond Durability - What Biomarkers Reveal About Disease Control
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
Macular Leakage: Indicator of Vascular Stability
MinuteCE®
Macular Leakage: Indicator of Vascular Stability
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®
Signs of Progress: PED as a Predictor of Disease and Outcomes
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended